在功能衰竭中滴毒素毒性:在Fab疗法失败后通过血交换解决方案
Jeremy M Williams1, Pramod Reddy1
1Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
Cureus
|December 16, 2025
概括
患有脏疾病的患者的迪戈辛毒性可能具有挑战性. 血交换 (PLEX) 在标准治疗失败时,为持续的迪戈辛毒性提供了潜在的救援疗法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床毒理学 临床毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 迪戈辛毒性对患有慢性病 (CKD) 的患者构成重大风险,原因是药物清除受损.
- 标准的迪戈辛特异性抗体片段 (Fab) 治疗在严重情况下可能不足,导致反弹毒性.
研究的目的:
- 在患有急性功能衰竭的患者中呈现急性-慢性迪戈辛毒性病例.
- 评估血交换 (PLEX) 作为持续的迪戈辛毒性治疗的救援疗法的疗效,而这种药物对Fab疗法没有反应.
主要方法:
- 一个73岁妇女的病例报告,患有急性-慢性迪戈辛毒性和急性功能衰竭.
- 给予狄戈辛特异性抗体片段 (Fab),然后进行血交换 (PLEX).
主要成果:
- 患者经历了持续的狄戈辛毒性症状,尽管初始的Fab治疗.
- 血交换成功地去除了狄戈辛-Fab复合物和自由狄戈辛,导致临床解决.
- 在PLEX后没有观察到毒性的复发.
结论:
- 血交换 (PLEX) 可以在患有功能障碍和持续症状的患者中,尽管接受了Fab治疗,但对于迪戈辛毒性来说是一种有效的救援疗法.
- PLEX可能有助于通过清除毒素-Fab复合体在脏清除受损的患者预防反弹毒性.
相关概念视频
Renal Failure: Dose Adjustments
404
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
404
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
354
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
354
Acute Kidney Injury V: Interprofessional Care
277
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
277
Dialysis
1.1K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Heart Failure Drugs: Diuretics
764
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
764


